Reportable segment operating profit
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $1.2B | $1.1B | $1.2B | $1.2B | $500.0M | $828.0M | $877.0M | $899.0M |
| Neuroscience | $991.0M | $961.0M | $1.0B | $1.1B | $384.0M | $705.0M | $740.0M | $737.0M |
| Medical Surgical | $658.0M | $690.0M | $774.0M | $765.0M | $259.0M | $494.0M | $531.0M | $499.0M |
| Diabetes Group | $100.0M | $102.0M | $116.0M | $136.0M | -$57.0M | $26.0M | $53.0M | $57.0M |
| Other operating segment | — | — | — | $13.0M | $6.0M | $11.0M | $9.0M | -$1.0M |
| Total | $1.4B | $1.3B | $1.6B | $1.6B | $1.5B | $1.4B | $1.7B | $1.5B |
Segments
NeuroscienceView metric
Other operating segmentView metric
CardiovascularView metric
Medical SurgicalView metric
Diabetes GroupView metric